Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. Sonke

P3.16-17 Cardiac Sparing in Stereotactic Body Radiotherapy of Early Stage NSCLC Patients

Journal of Thoracic Oncology

English

MA 13.09 Toxicity and Second Primary Lung Cancers in Late Survivors Following Lung SBRT

Journal of Thoracic Oncology

English

P1.17-07 the Prognostic Value of Volumetric Changes of the GTV Measured on CBCT During Radiotherapy for CCRT in NSCLC Patients

Journal of Thoracic Oncology

English

P3.01-26 a Framework for Systematic Clinical Evaluation of Technical Innovations in Lung Cancer Patients Treated on the MR-Linac (MRL)

Journal of Thoracic Oncology

English

Poor Pulmonary Function Is Not Associated With Increased Rates of Toxicity or Decreased Overall Survival After Stereotactic Body Radiotherapy for Early Stage Non-Small Cell Lung Cancer: Results of a Multi-Institutional Analysis

2010

English

Time Interval Between Staging FDG Positron Emission Tomography (PET) and Initiation of Stereotactic Lung Radiotherapy (SBRT) Impacts the Risk of Recurrence and Metastasis in Non-Small Cell Lung Cancer (NSCLC)

2010

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. Sonke

P3.16-17 Cardiac Sparing in Stereotactic Body Radiotherapy of Early Stage NSCLC Patients

MA 13.09 Toxicity and Second Primary Lung Cancers in Late Survivors Following Lung SBRT

P1.17-07 the Prognostic Value of Volumetric Changes of the GTV Measured on CBCT During Radiotherapy for CCRT in NSCLC Patients

P3.01-26 a Framework for Systematic Clinical Evaluation of Technical Innovations in Lung Cancer Patients Treated on the MR-Linac (MRL)

Poor Pulmonary Function Is Not Associated With Increased Rates of Toxicity or Decreased Overall Survival After Stereotactic Body Radiotherapy for Early Stage Non-Small Cell Lung Cancer: Results of a Multi-Institutional Analysis

Time Interval Between Staging FDG Positron Emission Tomography (PET) and Initiation of Stereotactic Lung Radiotherapy (SBRT) Impacts the Risk of Recurrence and Metastasis in Non-Small Cell Lung Cancer (NSCLC)